|1.||Sahin-Tóth, Miklós: 23 articles (07/2015 - 06/2002)|
|2.||Lerch, Markus M: 15 articles (03/2015 - 02/2002)|
|3.||Teich, Niels: 13 articles (01/2010 - 02/2002)|
|4.||Witt, Heiko: 11 articles (09/2015 - 05/2002)|
|5.||Mössner, Joachim: 11 articles (01/2011 - 02/2002)|
|6.||Whitcomb, David C: 10 articles (12/2012 - 09/2002)|
|7.||Keim, Volker: 10 articles (01/2010 - 02/2002)|
|8.||Chen, J M: 10 articles (01/2008 - 07/2000)|
|9.||Férec, Claude: 9 articles (09/2015 - 02/2002)|
|10.||Chen, Jian-Min: 8 articles (09/2015 - 02/2002)|
01/01/2009 - "Only in intermediate pancreatitis was there a significant reduction of trypsinogen-activating peptide levels. "
01/01/2002 - "These findings lead us to conclude that HSP70 induction, rather than some other thermal stress-related phenomenon, mediates the thermal stress-induced protection against pancreatitis and that it protects against pancreatitis by preventing intrapancreatic activation of trypsinogen. "
01/01/2002 - "Thermal stress-induced HSP70 mediates protection against intrapancreatic trypsinogen activation and acute pancreatitis in rats."
01/01/1999 - "In pancreatitis, when trypsinogen is prematurely activated, PAR-2-mediated ductal secretion may promote clearance of toxins and debris."
10/03/2014 - "Here, we aim to investigate ER stress in CP, study its pathogenesis in relation to trypsinogen activation (widely regarded as the key event of pancreatitis), and explore its mechanism, time course, and downstream consequences during pancreatic injury. "
|2.||Cystic Fibrosis (Mucoviscidosis)
09/12/1991 - "To evaluate the feasibility and efficacy of measuring immunoreactive trypsinogen in blood to screen for cystic fibrosis, we performed this test in 279,399 newborns in Colorado from 1982 to 1987. "
09/12/1991 - "Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations."
05/01/2002 - "Genetic studies revealed mutations in the cationic trypsinogen gene and an increased frequency of cystic fibrosis gene mutations in patients with CP. "
05/01/2015 - "To test the hypothesis that multiple constituents of the apical plasma membrane residing alongside the causal cystic fibrosis (CF) transmembrane conductance regulator protein, including known CF modifiers SLC26A9, SLC6A14, and SLC9A3, would be associated with prenatal exocrine pancreatic damage as measured by newborn screened (NBS) immunoreactive trypsinogen (IRT) levels. "
12/01/2012 - "Newborn screening for cystic fibrosis (CF) relies on the measurement of immunoreactive trypsinogen (IRT) originating from the pancreas. "
04/01/2008 - "A loss of function polymorphism (G191R) of anionic trypsinogen (PRSS2) confers protection against chronic pancreatitis."
07/01/1999 - "This study was conducted to determine the spectrum and frequency of cationic trypsinogen mutations in unrelated patients with idiopathic or hereditary chronic pancreatitis (CP). "
09/01/2015 - "A genome-wide association study reported an association of chronic pancreatitis (CP) with variants in PRSS1-PRSS2 (rs10273639; near the gene encoding cationic trypsinogen) and CLDN2-MORC4 loci (rs7057398 in RIPPLY1 and rs12688220 in MORC4). "
03/01/2015 - "Gene conversion between cationic trypsinogen (PRSS1) and the pseudogene trypsinogen 6 (PRSS3P2) in patients with chronic pancreatitis."
03/01/2014 - "HP diagnosis is defined by the presence of a detected cationic trypsinogen gene mutation (with or without clinical or radiological manifestations of chronic pancreatitis) or when the patient's family satisfies the requirements of the EUROPAC. "
05/01/2012 - "These findings demonstrate that neutrophil-derived MMP-9 is a potent activator of trypsinogen in acinar cells and regulates pathological inflammation and tissue damage in AP."
12/01/2011 - "However, progression of local and systemic inflammation in AP does not require trypsinogen activation. "
05/01/2011 - "Moreover, these results suggest that LFA-1-mediated inflammation is a downstream component of trypsinogen activation in the pathophysiology of AP. "
09/01/2002 - "Clinical judgement predicts 1/3 of the severe cases on admission and early markers for either inflammation or trypsinogen activation should accurately identify 50-60% of the mild cases among the rest, thus missing only 2-4% of the remaining severe cases. "
09/01/2014 - "The present study supports a multifaceted pathogenesis for acute pancreatitis in which intra-acinar trypsinogen activation, damage to acinar cells, fat cells, and vascular cells as well as activation/degranulation of mast cells and activated macrophages all contribute to the initiation and/or progression of acute inflammation of the exocrine pancreas. "
12/01/2011 - "Absence of trypsinogen activation in T(-/-) mice led to near complete inhibition of acinar cell death in vitro and a 50% reduction in acinar necrosis during AP progression. "
01/01/2000 - "In the pancreas, trypsinogen activation is accompanied by PLA(2)-I activation in patients with pancreatic necrosis. "
04/01/1995 - "Trypsinogen activation preceded the development of pancreatic necrosis. "
01/01/1992 - "This is accompanied by an increase in lysosomal enzyme activity and activation of trypsinogen which finally leads to cellular necrosis. "
01/01/2014 - "Mutations in human cationic trypsinogen (PRSS1) are associated with HP and have provided some insight into the pathogenesis of pancreatitis, but mechanisms responsible for the initiation of pancreatitis have not been elucidated and the role of apoptosis and necrosis has been much debated. "
|1.||DNA (Deoxyribonucleic Acid)
|5.||Lipase (Acid Lipase)
|8.||Endothelin A Receptor